| Literature DB >> 35479107 |
Mariana Dumitru Taliha1, Eric Balti2, Evelyne Maillart3, Sophie Leemans3, Maxime Taghavi4, Sergiu-Andrei Carausu5, Said Sanoussi6, Bhavna Mahadeb7, Philippe Clevenbergh3.
Abstract
Non-typhoidal Salmonella (NTS) disease is usually a self-limiting infection presenting with digestive symptoms. However, disseminated presentation with involvement of secondary infectious sites is observed. We report diagnostic specificities and challenges related to the management of three patients with invasive NTS (iNTS) and secondary infectious locations. Among the seven patients (age range 46 - 83 years), four (two with extra-digestive infectious sites) had at least one immune debilitating condition. Two patients were incidentally discovered with iNTS and deceased after developing a septic shock despite antimicrobial treatment. Two individuals recovered under medical treatment without complications. Three other patients presented with secondary infectious sites. Case 1 suffered from urinary tract infection and dorsolumbar spondylodiscitis that responded well to antimicrobials and surgery. Abdominal prosthetic aortic aneurysm was diagnosed in case 2 and medical treatment only was applied. After four years of follow-up, he remains under antimicrobial treatment. Case 3 presented with conjoint thoracic aortic aneurysm and cutaneous abscesses managed with antimicrobials and surgery. Atherosclerosis and previous vascular intervention were the predisposing events for vascular involvement. iNTS is a serious disease carrying a high risk of mortality or secondary locations. Secondary locations can be managed by long duration antimicrobial therapy combined with surgery. Spine and aortitis are the most frequent secondary locations. Multi-drug resistant NTS represent an additional risk of mortality. Public health measures should be implemented to limit the spread of NTS to humans and the emergence of drug resistance.Entities:
Keywords: Antimicrobial resistance; Aortitis; Invasive disease; Mortality/morbidity; Non-typhoidal Salmonella; Spondylodiscitis
Year: 2022 PMID: 35479107 PMCID: PMC9036139 DOI: 10.1016/j.idcr.2022.e01498
Source DB: PubMed Journal: IDCases ISSN: 2214-2509
Description of the overall population of patients with invasive non-typhoidal salmonella disease diagnosed during the study period.
| Case 1 | 66 | Male | Back pain, mictalgia, pollakiuria, light sweating and anorexia (3 weeks) | COPDRA under methylprednisolone | None | Not available | Urinary tract Dorsal and lumbar spines (spondylodiscitis) | Total antimicrobial treatment 15 weeks Surgical management Infection control after 14 weeks | |
| Case 2 | 79 | Male | Fever, chills and diarrhea (3 days) | Aortoiliac aneurysm Embolization of hypogastric aneurysm | Return from SSA | Hypogastric mycotic aneurysm | Optimal infectious control under antimicrobials Ongoing treatment (4 years follow-up) No surgical management | ||
| Case 3 | 64 | Female | Multiple bilateral abscesses of the thighs (5 weeks) | Myasthenia gravis under azathioprine and methylprednisolone Type 2 diabetes mellitus Radiofrequency ablation of varicose veins | None from the patient * | Subcutaneous and cutaneous Mycotic aortic aneurysm | Surgical resection of aortic aneurysm and pericardial patch Eight weeks course of antimicrobials Systemic infectious Control with persistent positive rectal swab | ||
| Case 4 | 73 | Male | Elective post tibio-popliteal bypass surgery - Incidental finding (5 days post-surgery) | Type 2 diabetes mellitus ESRD | Residence in SSA the previous year | None identified | Antimicrobial treatment Dead as a result of septic shock at day 11 | ||
| Case 5 | 83 | Male | NSTEMI - Incidental finding (4 days after admission) | Not known | None | None identified | Antimicrobial treatment Dead as a result of septic shock and spontaneous pneumothorax at the ICU at day 10 | ||
| Case 6 | 46 | Male | Diarrhea and abdominal pain (10 days) | Digestive (pancreatic) adenocarcinoma under chemotherapy§ | None | Not available | None identified | Optimal infection control under antimicrobial treatment | |
| Case 7 | 38 | Male | Diarrhea and abdominal pain (2 days) | None | None | None identified | Optimal infection control under antimicrobial treatment |
# Also present in urinary sample, * The son of the patient returned from Asia few months prior to the presentation and beginning of the current illness. Attempts to test the son were unsuccessful, § Gemcitabine and oxaliplatine, COPD: chronic obstructive pulmonary disease, RA: rheumatoid arthritis, SSA: Sub-Saharan Africa, ESRD: end stage renal disease, NSTEMI: non-ST segment elevation myocardial infarction, ICU: intensive care unit.
Initial biological parameters of patients with secondary septic sites.
| Case 1 | Case 2 | Case 3 | |
|---|---|---|---|
| Hemoglobin, g/dL | 13.1 | 9.9 | 12.4 |
| White blood cells, 103/ µl | 8.16 | 8.30 | 8.49 |
| Platelets, 103/µl | 120 | 327 | 333 |
| C-reactive protein, mg/L | 169 | 335 | 81 |
| Urea, mg/dL | 112 | 98 | 43 |
| Creatinine, mg/dL | 1.46 * | 2.36 | 0.79 |
| eGFR, ml/min/1.73 m2 | 49 | 25 | 79 |
| AST, IU/L | 63 | 89 | 16 |
| ALT, IU/L | 72 | 67 | 20 |
| GGT, IU/L | 276 | 227 | 53 |
| ALP, IU/L | 288 | 263 | 72 |
| Lipase, IU/L | 10 | 126# | 74# |
| Plasma glucose level, mmol/L* * | 8.05 | 7.38 | 26.36 |
| HbA1c, mmol/mol | 45 | na | 107 |
eGFR: estimated glomerular filtration rate, AST: aspartate aminotransferase, ALT: alanine aminotransferase, GGT: gamma glutamyl-transpeptidase, ALP: alkaline phosphatase, IU: international unit, HbA1c: glycated hemoglobin, na: not applicable, *baseline value 0.86 mg/dL and optimal correction after infection control, # without signs of pancreatitis at tomodensitometric examination, ** random value.
Fig. 1Sagittal bone window reconstruction from an abdominal CT scan. Multiple vertebral fractures (T11, T12, L1, L3, L5) with lysis of the vertebral bodies of T11, T12 and L1 (arrows).
Fig. 2Spine MRI sagittal STIR, sagittal and axial T1 weighted images after gadolinium injection before (A, B and C, respectively) and after (D, E and F, respectively) medical treatment and before surgical management. Spondylodiscitis T12-L1 with destructive discovertebral collection (thick arrow) and right paravertrebral collection (thin arrow).
Fig. 3PET and CT scan fusion (A) and abdominal CT scan after injection of contrast media (B) axial views. Abdominal aortic aneurysm with endograft surrounded by multiple infective collections (thick arrow). Gas bubbles within a periaortic collection (thin arrow).
Fig. 4CT angiography coronal (A) and parasagittal (B) views and Volume Rendering Technique reconstruction (C). Saccular aneurysm of the transverse aortic arch.